FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

332219005: Tazarotene 0.05% aqueous gel (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    468693015 Tazarotene 0.05% aqueous gel en Synonym Active Entire term case insensitive SNOMED CT core module
    1192680016 Tazarotene 0.05% aqueous gel (product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    2164805016 Tazarotene 0.05% gel en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Tazarotene 0.05% aqueous gel Is a Product containing tazarotene false Inferred relationship Existential restriction modifier
    Tazarotene 0.05% aqueous gel Is a Product containing tazarotene false Inferred relationship Existential restriction modifier
    Tazarotene 0.05% aqueous gel Has active ingredient Skin agent false Inferred relationship Existential restriction modifier
    Tazarotene 0.05% aqueous gel Has active ingredient Tazarotene false Inferred relationship Existential restriction modifier
    Tazarotene 0.05% aqueous gel Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
    Tazarotene 0.05% aqueous gel Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
    Tazarotene 0.05% aqueous gel Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
    Tazarotene 0.05% aqueous gel Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
    Tazarotene 0.05% aqueous gel VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Tazarotene 0.05% aqueous gel VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Tazarotene 0.05% aqueous gel Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
    Tazarotene 0.05% aqueous gel Has specific active ingredient Tazarotene false Inferred relationship Existential restriction modifier
    Tazarotene 0.05% aqueous gel Has dispensed dose form Gel false Inferred relationship Existential restriction modifier
    Tazarotene 0.05% aqueous gel Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Tazarotene 0.05% aqueous gel - product Is a False Tazarotene 0.05% aqueous gel Inferred relationship Existential restriction modifier
    Zorac 0.05% gel (Allergan Ltd) Is a False Tazarotene 0.05% aqueous gel Inferred relationship Existential restriction modifier
    Tazarotene 0.05% gel 60 gram Is pack of False Tazarotene 0.05% aqueous gel Inferred relationship Existential restriction modifier
    Tazarotene 0.05% gel 30 gram Is pack of False Tazarotene 0.05% aqueous gel Inferred relationship Existential restriction modifier
    Zorac 0.05% gel (Sigma Pharmaceuticals Plc) Is a False Tazarotene 0.05% aqueous gel Inferred relationship Existential restriction modifier
    Tazarotene 0.05% gel 60 gram Has VMP False Tazarotene 0.05% aqueous gel Inferred relationship Existential restriction modifier
    Tazarotene 0.05% gel 30 gram Has VMP False Tazarotene 0.05% aqueous gel Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start